Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 46 Records) |
| Query Trace: Breast Neoplasms and FGFR1[original query] |
|---|
| Circulating Tumor DNA Markers for Early Progression on Fulvestrant With or Without Palbociclib in ER+ Advanced Breast Cancer. Journal of the National Cancer Institute 2020 9 113 (3): 309-317. O'Leary Ben, Cutts Rosalind J, Huang Xin, Hrebien Sarah, Liu Yuan, André Fabrice, Loibl Sibylle, Loi Sherene, Garcia-Murillas Isaac, Cristofanilli Massimo, Bartlett Cynthia Huang, Turner Nicholas |
| Impact of fibroblast growth factor receptor 1 (FGFR1) amplification on the prognosis of breast cancer patients. Breast cancer research and treatment 2020 8 184 (2): 311-324. Erber Ramona, Rübner Matthias, Davenport Simon, Hauke Sven, Beckmann Matthias W, Hartmann Arndt, Häberle Lothar, Gass Paul, Press Michael F, Fasching Peter |
| Clinical implications of prospective genomic profiling of metastatic breast cancer patients. Breast cancer research : BCR 2020 Aug 22 (1): 91. van Geelen Courtney T, Savas Peter, Teo Zhi Ling, Luen Stephen J, Weng Chen-Fang, Ko Yi-An, Kuykhoven Keilly S, Caramia Franco, Salgado Roberto, Francis Prudence A, Dawson Sarah-Jane, Fox Stephen B, Fellowes Andrew, Loi Shere |
| Limited Practical Utility of Liquid Biopsy in the Treated Patients with Advanced Breast Cancer. Diagnostics (Basel, Switzerland) 2020 Jul 10 (8): . Niwinska Anna, Ba?abas Aneta, Kulecka Maria, Kluska Anna, Pi?tkowska Magdalena, Paziewska Agnieszka, Py?niak Kazimiera, Olszewski Wojciech, Mikula Micha?, Ostrowski Jer |
| Characterizations of Cancer Gene Mutations in Chinese Metastatic Breast Cancer Patients. Frontiers in oncology 2020 7 10 1023. Tao Zhonghua, Li Ting, Feng Zhe, Liu Chang, Shao Yilin, Zhu Mingyu, Gong Chengcheng, Wang Biyun, Cao Jun, Wang Leipin, Du Yiqun, Lizaso Analyn, Li Bing, Zhang Jian, Hu Xich |
| FGFR aberrations increase the risk of brain metastases and predict poor prognosis in metastatic breast cancer patients. Therapeutic advances in medical oncology 2020 12 1758835920915305. Xie Ning, Tian Can, Wu Hui, Yang Xiaohong, Liu Liping, Li Jing, Xiao Huawu, Gao Jianxiang, Lu Jun, Hu Xuming, Cao Min, Shui Zhengrong, Tang Yu, Wang Xiao, Yang Jianbo, Hu Zhe-Yu, Ouyang Qucha |
| Shallow Whole-Genome Sequencing from Plasma Identifies FGFR1 Amplified Breast Cancers and Predicts Overall Survival. Cancers 2020 6 12 (6): . Bourrier Chantal, Pierga Jean-Yves, Xuereb Laura, Salaun Hélène, Proudhon Charlotte, Speicher Michael R, Belic Jelena, Heitzer Ellen, Lockhart Brian Paul, Guigal-Stephan Nolw |
| Comparison of BRCA versus non-BRCA germline mutations and associated somatic mutation profiles in patients with unselected breast cancer. Aging 2020 Feb 12 . Chen Bo, Zhang Guochun, Li Xuerui, Ren Chongyang, Wang Yulei, Li Kai, Mok Hsiaopei, Cao Li, Wen Lingzhu, Jia Minghan, Li Cheukfai, Guo Liping, Wei Guangnan, Lin Jiali, Li Yingzi, Zhang Yuchen, Han-Zhang Han, Liu Jing, Lizaso Analyn, Liao Ni |
| The Use of Serial Circulating Tumor DNA to Detect Resistance Alterations in Progressive Metastatic Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2020 Dec . Jacob Saya, Davis Andrew A, Gerratana Lorenzo, Velimirovic Marko, Shah Ami N, Wehbe Firas, Katam Neelima, Zhang Qiang, Flaum Lisa, Siziopikou Kalliopi P, Platanias Leonidas C, Gradishar William J, Behdad Amir, Bardia Aditya, Cristofanilli Massi |
| A comprehensive pan-cancer study of fibroblast growth factor receptor aberrations in Chinese cancer patients. Annals of translational medicine 2020 11 8 (20): 1290. Sun Yi, Li Gao, Zhu Wei, He Qiuyan, Liu Yongchang, Chen Xianshan, Liu Juan, Lin Jing, Han-Zhang Han, Yang Zheng, Lizaso Analyn, Xiang Jianxing, Mao Xinru, Liu Hao, Gao Ya |
| Identifying Genomic Alterations in Patients With Stage IV Breast Cancer Using MammaSeq: An International Collaborative Study. Clinical breast cancer 2020 11 21 (3): 210-217. Shah Osama Shiraz, Soran Atilla, Sahin Mustafa, Knapick Beth A, Ugras Serdar, Celik Esin, Lucas Peter C, Lee Adrian |
| Genomic Aberrations and Late Recurrence in Postmenopausal Women with Hormone Receptor-positive Early Breast Cancer: Results from the SOLE Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 2020 10 27 (2): 504-512. Guerini-Rocco Elena, Gray Kathryn P, Fumagalli Caterina, Reforgiato Marta Rita, Leone Isabella, Rafaniello Raviele Paola, Munzone Elisabetta, Kammler Roswitha, Neven Patrick, Hitre Erika, Jerusalem Guy, Simoncini Edda, Gombos Andrea, Deleu Ines, Karlsson Per, Aebi Stefan, Chirgwin Jacquie, Di Lauro Vincenzo, Thompson Alastair, Graas Marie-Pascale, Barber Matthew, Fontaine Christel, Loibl Sibylle, Gavilá Joaquín, Kuroi Katsumasa, Müller Bettina, O'Reilly Seamus, Di Leo Angelo, Goldhirsch Aron, Viale Giuseppe, Barberis Massimo, Regan Meredith M, Colleoni Mar |
| Inter-tumor genomic heterogeneity of breast cancers: comprehensive genomic profile of primary early breast cancers and relapses. Breast cancer research : BCR 2020 Oct 22 (1): 107. Fumagalli Caterina, Ranghiero Alberto, Gandini Sara, Corso Federica, Taormina Sergio, De Camilli Elisa, Rappa Alessandra, Vacirca Davide, Viale Giuseppe, Guerini-Rocco Elena, Barberis Massi |
| TP53 mutations are associated with primary endocrine resistance in luminal early breast cancer. Cancer medicine 2021 Nov . Grote Isabel, Bartels Stephan, Kandt Leonie, Bollmann Laura, Christgen Henriette, Gronewold Malte, Raap Mieke, Lehmann Ulrich, Gluz Oleg, Nitz Ulrike, Kuemmel Sherko, Zu Eulenburg Christine, Braun Michael, Aktas Bahriye, Grischke Eva-Maria, Schumacher Claudia, Luedtke-Heckenkamp Kerstin, Kates Ronald, Wuerstlein Rachel, Graeser Monika, Harbeck Nadia, Christgen Matthias, Kreipe Ha |
| Shallow WGS of individual CTCs identifies actionable targets for informing treatment decisions in metastatic breast cancer. British journal of cancer 2022 Sep . Fernandez-Garcia Daniel, Nteliopoulos Georgios, Hastings Robert K, Rushton Amelia, Page Karen, Allsopp Rebecca C, Ambasager Bana, Gleason Kelly, Guttery David S, Ali Simak, Charles Coombes R, Shaw Jacqueline |
| Genomic Markers of CDK 4/6 Inhibitor Resistance in Hormone Receptor Positive Metastatic Breast Cancer. Cancers 2022 7 14 (13): . Lee Jin Sun, Yost Susan E, Li Sierra Min, Cui Yujie, Frankel Paul H, Yuan Yate-Ching, Schmolze Daniel, Egelston Colt A, Guo Weihua, Murga Mireya, Chang Helen, Bosserman Linda, Yuan Yu |
| Genomic Landscape of Advanced Solid Tumors in Circulating Tumor DNA and Correlation With Tissue Sequencing: A Single Institution's Experience. JCO precision oncology 2022 6 6 e2100289. Gerratana Lorenzo, Movarek Michael, Wehbe Firas, Katam Neelima, Mahalingam Devalingam, Donahue Jeannine, Shah Ami, Chae Young K, Mulcahy Mary, Tsarwhas Dean, Villaflor Victoria, Kalyan Aparna, Hussein Maha, Patel Jyoti, Chandra Sunandana, Platanias Leonidas C, Gradishar William, Cristofanilli Massimo, Behdad Am |
| Gene Mutations Associated With Clinical Characteristics in the Tumors of Patients With Breast Cancer. Frontiers in oncology 2022 12 778511. Hao Chunfang, Wang Chen, Lu Ning, Zhao Weipeng, Li Shufen, Zhang Li, Meng Wenjing, Wang Shuling, Tong Zhongsheng, Zeng Yanwu, Lu Leil |
| Identification of mutation patterns and circulating tumour DNA-derived prognostic markers in advanced breast cancer patients. Journal of translational medicine 2022 05 20 (1): 211. Liao Hao, Zhang Jiayang, Zheng Tiantian, Liu Xiaoran, Zhong Jianxin, Shao Bin, Dong Xiaoxi, Wang Xiaohong, Du Pan, King Bonnie L, Jia Shidong, Yu Jianjun, Li Huipi |
| Combined PIK3CA and FGFR Inhibition With Alpelisib and Infigratinib in Patients With PIK3CA-Mutant Solid Tumors, With or Without FGFR Alterations. JCO precision oncology 2022 2 3 1-13. Hyman David M, Tran Ben, Paz-Ares Luis, Machiels Jean-Pascal, Schellens Jan H, Bedard Philippe L, Campone Mario, Cassier Philippe A, Sarantopoulos John, Vaishampayan Ulka, Chugh Rashmi, Mahipal Amit, Lockhart A Craig, Sessa Cristiana, Zander Thomas, Ng Matthew, Curigliano Giuseppe, Bendiske Jennifer, Chen Xueying, Choudhury Somesh, Graus-Porta Diana, Lewis Nancy, Perez Garcia Jose Manuel, de Miguel-Luken María Jo |
| The role of next-generation sequencing in the examination of signaling genes in Brca1/2-negative breast cancer cases. Annals of human genetics 2022 Dec . Cine Naci, Ugurtas Cansu, Gokbayrak Merve, Aydin Duygu, Demir Gulhan, Kuru Seda, Sunnetci-Akkoyunlu Deniz, Eren-Keskin Seda, Simsek Turgay, Cabuk Devrim, Aksu Maksut Gorkem, Canturk Nuh Zafer, Savli Hak |
| Profiling the somatic mutational landscape of breast tumors from Hispanic/Latina women reveals conserved and unique characteristics. Cancer research 2023 5 . Yuan Chun Ding, Hanbing Song, Aaron W Adamson, Daniel Schmolze, Donglei Hu, Scott Huntsman, Linda Steele, Carmina S Patrick, Shu Tao, Natalie Hernandez, Charleen D Adams, Laura Fejerman, Kevin Gardner, Anna María Nápoles, Eliseo J Perez-Stable, Jeffrey N Weitzel, Henrik Bengtsson, Franklin W Huang, Susan L Neuhausen, Elad Z |
| ER+, HER2- advanced breast cancer treated with taselisib and fulvestrant: genomic landscape and associated clinical outcomes. Molecular oncology 2023 3 . Chen Jessica W, Jacot William, Cortés Javier, Krop Ian E, Dent Susan, Harbeck Nadia, De Laurentiis Michelino, Diéras Véronique, Im Young-Hyuck, Stout Thomas J, Schimmoller Frauke, Savage Heidi M, Hutchinson Katherine E, Wilson Timothy |
| Prevalent landscape of tumor genomic alterations of luminal B1 breast cancers using a comprehensive genomic profiling assay in Taiwan. Breast cancer (Tokyo, Japan) 2023 12 . Bo-Fang Chen, Yi-Fang Tsai, Pei-Ju Lien, Yen-Shu Lin, Chin-Jung Feng, Yen-Jen Chen, Han-Fang Cheng, Chun-Yu Liu, Ta-Chung Chao, Jiun-I Lai, Ling-Ming Tseng, Chi-Cheng Hua |
| Clinicopathologic and genetic analysis of invasive breast carcinomas in women with germline CHEK2 variants. Breast cancer research and treatment 2023 12 . Christopher J Schwartz, Nikka Khorsandi, Amie Blanco, Rita A Mukhtar, Yunn-Yi Chen, Gregor Krin |
| The ctDNA-based postoperative molecular residual disease status in different subtypes of early-stage breast cancer. Gland surgery 2023 1 11 (12): 1924-1935. Yang Yang, Zhang Jie, Li Jiao-Yang, Xu Lu, Wang Si-Ning, Zhang Jun-Qi, Xun Zhou, Xia Yu, Cao Jian-Bo, Liu Yang, Shi Li-Yan, Li Wei, Shi Yong-Lei, He Yuan-Ge, Gu De-Jian, Yu Zheng-Yuan, Chen Kai, Lan Ji |
| Significance of Multi-Cancer Genome Profiling Testing for Breast Cancer: A Retrospective Analysis of 3326 Cases from Japan's National Database. Genes 2024 6 15 (6): . Kyoka Kawabata, Hinano Nishikubo, Saki Kanei, Rika Aoyama, Yuki Tsukada, Tomoya Sano, Daiki Imanishi, Takashi Sakuma, Koji Maruo, Yurie Yamamoto, Qiang Wang, Zhonglin Zhu, Canfeng Fan, Masakazu Yashi |
| Comprehensive genomic profiling and therapeutic implications for Taiwanese patients with treatment-naïve breast cancer. Cancer medicine 2024 6 13 (12): e7384. Shang-Hung Chen, Ka-Po Tse, Yen-Jung Lu, Shu-Jen Chen, Yu-Feng Tian, Kien Thiam Tan, Chien-Feng |
| Clinicogenomic characterization of inflammatory breast cancer. bioRxiv : the preprint server for biology 2024 5 . Nolan Priedigkeit, Beth Harrison, Robert Shue, Melissa Hughes, Yvonne Li, Gregory J Kirkner, Liam F Spurr, Marie Claire Remolano, Sarah Strauss, Janet Files, Anne-Marie Feeney, Libby Grant, Ayesha Mohammed-Abreu, Ana Garrido-Castro, Romualdo Barroso Sousa, Brittany Bychkovsky, Faina Nakhlis, Jennifer R Bellon, Tari A King, Eric P Winer, Neal Lindeman, Bruce E Johnson, Lynette Sholl, Deborah Dillon, Beth Overmoyer, Sara M Tolaney, Andrew Cherniack, Nancy U Lin, Filipa Lyn |
| Phase II Study of Erdafitinib in Patients With Tumors With FGFR Amplifications: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K1. JCO precision oncology 2024 4 8 e2300406. Jun Gong, Alain C Mita, Zihan Wei, Heather H Cheng, Edith P Mitchell, John J Wright, S Percy Ivy, Victoria Wang, Robert C Gray, Lisa M McShane, Larry V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Ajjai S Alva, James V Tricoli, Barbara A Conley, Carlos L Arteaga, Lyndsay N Harris, Peter J O'Dwyer, Alice P Chen, Keith T Flaher |
- Page last reviewed:Feb 1, 2024
- Content source: